CorMedix (CRMD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $810 thousand versus the consensus estimate of $1.66 million.
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluent (FLNT) Tops Q2 EPS by 4c
- Apollo Commercial Real Estate Finance (ARI) Misses Q2 EPS by 2c
- Microvast Holdings (MVST) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
